Clozapine - CAS 5786-21-0
Catalog number:
5786-21-0
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C18H19ClN4
Molecular Weight:
326.82
COA:
Inquire
Targets:
Dopamine Receptor
Description:
Clozapine is an atypical antipsychotic drug by acting as a 5-HT antagonist, used in the treatment of schizophrenia.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Synonyms:
HF 1854, LX 100-129
MSDS:
Inquire
1.Very Low Dose Amitriptyline for Clozapine-Associated Sialorrhea.
Sinha S1, Simlai J2, Praharaj SK3. Curr Drug Saf. 2016 Apr 26. [Epub ahead of print]
Clozapine is the antipsychotic of choice for resistant schizophrenia, but its widespread use is limited by adverse effects. Sialorrhea is a common and troublesome adverse effect seen with clozapine which leads to poor compliance. Several treatment strategies are advocated, no single treatment is considered superior. Amitriptyline, a tricyclic antidepressant, has been found to be useful for clozapine-associated sialorrhea at 87-100 mg per day. We report the effect of very low dose amitriptyline (10 mg per day) in a patient with clozapine-associated sialorrhea. There was rapid and complete resolution of sialorrhea after three days without any emergent adverse effect.
2.Use of Clozapine for Borderline Personality Disorder: A Case Report.
Amamou B1, Salah WB1, Mhalla A1, Benzarti N1, Elloumi H1, Zaafrane F1, Gaha L1. Clin Psychopharmacol Neurosci. 2016 May 31;14(2):226-8. doi: 10.9758/cpn.2016.14.2.226.
Patients with borderline personality disorder (BPD) show significant impairment in functioning, particularly in the interpersonal and social domains. Prior reports suggest that clozapine may be effective in the management of BPD. We present the case of a patient with BPD who experienced persistent suicidal ideation and was treated with clozapine at a state psychiatric hospital. After treatment failure with other psychotropic medications, clozapine medication was initiated; not only did suicidal ideation cease, but social and professional functioning also greatly improved to the point of no longer requiring intensive levels of observation or restrictive procedures. Clozapine appears to be efficacious in the management of suicide attempts and self-injurious behavior. Moreover, it appears to be promising as a therapeutic measure for ameliorating the global functioning of patients with severe BPD. Larger, randomized, blinded, and controlled prospective studies are needed to confirm these findings and to determine optimal dosage.
3.Late Onset Agranulocytosis with Clozapine Associated with HLA DR4 Responding to Treatment with Granulocyte Colony-stimulating Factor: A Case Report and Review of Literature.
Singh A1, Grover S1, Malhotra P2, Varma SC2. Clin Psychopharmacol Neurosci. 2016 May 31;14(2):212-7. doi: 10.9758/cpn.2016.14.2.212.
Agranulocytosis as a side effect of clozapine has been reported to be associated with initial phases of treatment, i.e., first six months. Agranulocytosis with clozapine during the initial phases of treatment has been linked to genetic vulnerability in the form of variations in the human leukocyte-antigen haplotypes. However, there is limited literature on late onset agranulocytosis with clozapine and this has very rarely been linked to human leukocyte-antigen haplotypes vulnerability. In this report we review the existing data on late onset agranulocytosis with clozapine and describe the case of a young man, who developed agranulocytosis with clozapine after 35 months of treatment and was found to have genetic vulnerability in form of being positive for HLA DR4. This case highlights underlying autoimmune immune mechanism in clozapine-induced agranulocytosis and the need for frequent blood count monitoring on clozapine even after the initial 6 months of starting treatment especially in patients with genetic vulnerability to develop this condition.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Dopamine Receptor Products


CAS 440-17-5 Trifluoperazine Hydrochloride

Trifluoperazine Hydrochloride
(CAS: 440-17-5)

Trifluoperazine is a dopamine D2 receptor inhibitor with IC50 of 1.1 nM.

CAS 524-83-4 Etybenzatropine

Etybenzatropine
(CAS: 524-83-4)

Etybenzatropine is an anticholinergic/antihistamine. It is used as an antiparkinsonian agent. It may act as a dopamine reuptake inhibitor.

CAS 80751-65-1 SKF-82958 hydrobromide

SKF-82958 hydrobromide
(CAS: 80751-65-1)

SKF-82958 hydrobromide is a synthetic compound of the benzazepine class that acts as a D1/D5 receptor full agonist. It has characteristic anorectic effects, hyp...

CAS 1841-19-6 Fluspirilene

Fluspirilene
(CAS: 1841-19-6)

Fluspirilene, with antipsychotic activity, is a non-competitive antagonist of agonist-activated L-type calcium channels (IC50 = 0.03 µM). Fluspirilene is also a...

CAS 15676-16-1 Sulpiride

Sulpiride
(CAS: 15676-16-1)

Sulpiride, a D2 receptor a antagonist, with antipsychotic adn antidepressant properties it can be used to treat used in schizophrenia or senile dementia etc., b...

CAS 34161-24-5 Fipexide hydrochloride

Fipexide hydrochloride
(CAS: 34161-24-5)

Fipexide hydrochloride is a nootropic agent that displays a positive effect on cognitive function

CAS 5786-21-0 Clozapine

Clozapine
(CAS: 5786-21-0)

Clozapine is an atypical antipsychotic drug by acting as a 5-HT antagonist, used in the treatment of schizophrenia.

Amisulpride hydrochloride
(CAS: 81342-13-4)

Amisulpride hydrochloride could inhibit radioligand binding to native dopamine D2 receptor in membranes from the rat striatum with an IC50 value of 21nM. It has...

CAS 18016-80-3 Lisuride

Lisuride
(CAS: 18016-80-3)

Lisuride, an indoloquinoline derivative, has been found to be a dopamine D2 receptor agonist and could probably be effective in antimigraine as well as antipark...

CAS 7416-34-4 Molindone

Molindone
(CAS: 7416-34-4)

Molindone is dopamine D2 receptor antagonist which can be used in the treatment of schizophrenia. Molindone can block the effects of dopamine in the brain, lead...

CAS 67227-56-9 Fenoldopam

Fenoldopam
(CAS: 67227-56-9)

Fenoldopam is a selective D1 receptor partial agonist, binds to α2-adrenoceptors, increasing renal blood flow used as an antihypertensive agent.

CAS 67227-57-0 Fenoldopam Mesylate

Fenoldopam Mesylate
(CAS: 67227-57-0)

Fenoldopam is a selective D1 receptor partial agonist, binds to α2-adrenoceptors, increasing renal blood flow used as an antihypertensive agent.

Iloperidone hydrochloride
(CAS: 1299470-39-5)

The hydrochloride salt form of Iloperidone which is a antagonist of both D2 and 5-HT2 receptor and has been commonly used against schizophrenia. IC50: 10-100 nm...

CAS 57645-91-7 Clebopride Malate

Clebopride Malate
(CAS: 57645-91-7)

Clebopride is a substituted benzamide as a dopamine antagonist used to treat functional gastrointestinal disorders.

Adrogolide Hydrochloride
(CAS: 166591-11-3)

The hydrochloride salt form of Adrogolide,a quinoline derivative, has been found to be a dopamine D1 receptor agonist that was once studied in Parkinson's disea...

Sarizotan HCl
(CAS: 195068-07-6)

Sarizotan, also known as EMD-128130, is a full 5-HT1a agonist and a dopamine D2-like agonist/partial agonist used in clinical trials for the treatment of l-dopa...

CAS 94424-50-7 Quinagolide hydrochloride

Quinagolide hydrochloride
(CAS: 94424-50-7)

CAS 132810-10-7 Blonanserin

Blonanserin
(CAS: 132810-10-7)

A 5-HT2 serotonin receptor and D2 dopamine receptor antagonist, used as an antipsychotic.

CAS 1148156-63-1 ST-836

ST-836
(CAS: 1148156-63-1)

ST-836, a dopamine receptor ligand, might have similar effect with dopamine and probably useful as an antiparkinsonian agent.

CAS 53-60-1 Promazine Hydrochloride

Promazine Hydrochloride
(CAS: 53-60-1)

Promazine Hydrochloride is a phenothiazine used in short-term treatment of disturbed behavior and as an antiemetic.

Chemical Structure

CAS 5786-21-0 Clozapine

Quick Inquiry

Verification code

Featured Items